Oversight for Clinical Uses of Autologous Adult Stem Cells: Lessons from International Regulations

Gerard Porter, Tamra Lysaght, Ian Kerridge, Douglas Sipp, Benjamin J. Capps

Research output: Contribution to journalComment/debatepeer-review

Abstract

Autologous adult stem cells (ASCs) are being administered by physicians for indications that have not been demonstrated as safe and effective in formal clinical trials. Examination of regulatory frameworks across five countries suggests that balancing the demands of research with clinical freedom has created structural weaknesses that are being exploited.
Original languageEnglish
Pages (from-to)647-651
JournalCell Stem Cell
Volume13
Issue number6
DOIs
Publication statusPublished - 2013

Fingerprint

Dive into the research topics of 'Oversight for Clinical Uses of Autologous Adult Stem Cells: Lessons from International Regulations'. Together they form a unique fingerprint.

Cite this